These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34182694)

  • 21. NO, nitrotyrosine, and cyclic GMP in signal transduction.
    Hanafy KA; Krumenacker JS; Murad F
    Med Sci Monit; 2001; 7(4):801-19. PubMed ID: 11433215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular signaling with nitric oxide and cyclic guanosine monophosphate.
    Martin E; Davis K; Bian K; Lee YC; Murad F
    Semin Perinatol; 2000 Feb; 24(1):2-6. PubMed ID: 10709849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Nitric oxide: the endogenous nitrate in the cardiovascular system].
    Tschudi MR; Lüscher TF
    Herz; 1996 Jun; 21 Suppl 1():50-60. PubMed ID: 8767925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide and cyclic GMP signaling.
    McDonald LJ; Murad F
    Proc Soc Exp Biol Med; 1996 Jan; 211(1):1-6. PubMed ID: 8594612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic nitric oxide synthase blockade desensitizes the heart to the negative metabolic effects of nitric oxide.
    Davidov T; Weiss HR; Tse J; Scholz PM
    Life Sci; 2006 Sep; 79(17):1674-80. PubMed ID: 16831448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NMDA and nitric oxide act through the cGMP signal transduction pathway to repress hypothalamic gonadotropin-releasing hormone gene expression.
    Belsham DD; Wetsel WC; Mellon PL
    EMBO J; 1996 Feb; 15(3):538-47. PubMed ID: 8599937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conventional and Unconventional Mechanisms for Soluble Guanylyl Cyclase Signaling.
    Gao Y
    J Cardiovasc Pharmacol; 2016 May; 67(5):367-72. PubMed ID: 26452163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional coupling of nitric oxide synthase and soluble guanylyl cyclase in controlling catecholamine secretion from bovine chromaffin cells.
    Schwarz PM; Rodriguez-Pascual F; Koesling D; Torres M; Förstermann U
    Neuroscience; 1998 Jan; 82(1):255-65. PubMed ID: 9483518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Influence of Nitric Oxide on Soluble Guanylate Cyclase Regulation by Nucleotides: ROLE OF THE PSEUDOSYMMETRIC SITE.
    Sürmeli NB; Müskens FM; Marletta MA
    J Biol Chem; 2015 Jun; 290(25):15570-15580. PubMed ID: 25907555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of the expression and activity of midbrain nitric oxide synthase and soluble guanylyl cyclase in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Chalimoniuk M; Lukacova N; Marsala J; Langfort J
    Neuroscience; 2006 Aug; 141(2):1033-1046. PubMed ID: 16716528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 1996 Albert Lasker Medical Research Awards. Signal transduction using nitric oxide and cyclic guanosine monophosphate.
    Murad F
    JAMA; 1996 Oct; 276(14):1189-92. PubMed ID: 8827977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective properties of nitric oxide.
    Chiueh CC
    Ann N Y Acad Sci; 1999; 890():301-11. PubMed ID: 10668435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of nitric oxide and soluble guanylyl cyclase.
    Krumenacker JS; Hanafy KA; Murad F
    Brain Res Bull; 2004 Feb; 62(6):505-15. PubMed ID: 15036565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide and cyclic guanosine monophosphate signaling in the eye.
    Murad F
    Can J Ophthalmol; 2008 Jun; 43(3):291-4. PubMed ID: 18443613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasoconstriction increases pulmonary nitric oxide synthesis and circulating cyclic GMP.
    Wilson PS; Thompson WJ; Moore TM; Khimenko PL; Taylor AE
    J Surg Res; 1997 Jun; 70(1):75-83. PubMed ID: 9228932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel effects of nitric oxide.
    Davis KL; Martin E; Turko IV; Murad F
    Annu Rev Pharmacol Toxicol; 2001; 41():203-36. PubMed ID: 11264456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of nitric oxide synthase and nitric oxide-receptive, cyclic GMP-producing structures in the rat brain.
    De Vente J; Hopkins DA; Markerink-Van Ittersum M; Emson PC; Schmidt HH; Steinbusch HW
    Neuroscience; 1998 Nov; 87(1):207-41. PubMed ID: 9722153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide, cell bioenergetics and neurodegeneration.
    Moncada S; Bolaños JP
    J Neurochem; 2006 Jun; 97(6):1676-89. PubMed ID: 16805776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway.
    Fedele E; Jin Y; Varnier G; Raiteri M
    Br J Pharmacol; 1996 Oct; 119(3):590-4. PubMed ID: 8894183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of neuronal nitric oxide and cyclic GMP formation by Ca2+.
    Mayer B; Klatt P; Böhme E; Schmidt K
    J Neurochem; 1992 Dec; 59(6):2024-9. PubMed ID: 1279121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.